|

FOLFIRINOX regimen Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Zhejiang Provincial People's Hospital1

Indications

  • Proterizumab1
  • LDRT1
  • PD-L11
  • PD-1 Inhibitor1
  • Pancreatic Cancer1

Other1 trial

LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.